Aurobindo Pharma USA acquires Lannett Company LLC for $250 million, expanding U.S. manufacturing capabilities and product ...

Image source: Getty Images. What: Shares of Lannett Company, Inc. (NYSE: LCI), a midsized generic drugmaker, packed on 25.2% last month, according to data from S&P Global Market Intelligence.

Hyderabad: In a major strategic move, Aurobindo Pharma Limited has announced that its wholly owned subsidiary, Aurobindo ...

Hyderabad: Amid rising fears of US President Donald Trump imposing tariffs on Indian pharma imports, Aurobindo Pharma is ...

In response to reporting fiscal second-quarter results, shares of Lannett Company, Inc. (NYSE: LCI), a producer of generic drugs, fell 11% as of 3:53 p.m. EST on Thursday. Here's a look at the ...

Founded in 1942, Lannett Company is a Philadelphia-based developer, manufacturer, marketer, and distributor of generic pharmaceuticals for a broad spectrum of indications. The company has seen its ...

Is Lannett Company, Inc. (NYSE:LCI) a good investment right now? We check hedge fund and billionaire investor sentiment before delving into hours of research. Hedge funds spend millions of dollars ...

PHILADELPHIA, Aug. 25, 2021 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today reported financial results for its fiscal 2021 fourth quarter and full year ended June 30, 2021. "With the ...

An evaluation of Lannett’s recent purchase of Kremers Urban provides insight into an appealing boost to the company’s product diversification and pipeline. A discussion of Lannett’s fall in ...

Lannett Company had seen its market cap tumble from $2.5 billion in early 2015 to below $500 million, all before announcing in August 2018 that JSP was walking away.

About Lannett Company, Inc.: Lannett Company, founded in 1942, develops, manufactures, packages, markets and distributes generic pharmaceutical products for a wide range of medical indications.